MedPath
HSA Approval

ARIPIPRAZOLE MEVON TABLETS 5 MG

SIN17182P

ARIPIPRAZOLE MEVON TABLETS 5 MG

ARIPIPRAZOLE MEVON TABLETS 5 MG

February 18, 2025

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05AX12

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

Pharmathen International S.A

Active Ingredients

Aripiprazole

5 mg

Aripiprazole

Documents

Package Inserts

EDL3.1b 1.4.3 Package Insert_ARIPI_Jan 25_clean.docx

Approved: February 18, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ARIPIPRAZOLE MEVON TABLETS 5 MG - HSA Approval | MedPath